These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 21388249
1. Potentiation by adrenaline of agonist-induced responses in normal human platelets in vitro. Haaland HD, Holmsen H. Platelets; 2011; 22(5):328-37. PubMed ID: 21388249 [Abstract] [Full Text] [Related]
2. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro. Steen VM, Holmsen H, Aarbakke G. Thromb Haemost; 1993 Sep 01; 70(3):506-13. PubMed ID: 8259557 [Abstract] [Full Text] [Related]
3. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN. Kinlough-Rathbone RL, Perry DW, Rand ML, Packham MA. Thromb Haemost; 1997 Apr 01; 77(4):741-7. PubMed ID: 9134653 [Abstract] [Full Text] [Related]
4. Synergism between thrombin and epinephrine in human platelets: different dose-response relationships for aggregation and dense granule secretion. Steen VM, Holmsen H. Thromb Haemost; 1985 Oct 30; 54(3):680-3. PubMed ID: 4089798 [Abstract] [Full Text] [Related]
5. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes. Winocour PD, Kinlough-Rathbone RL, Mustard JF. J Lab Clin Med; 1986 Feb 30; 107(2):148-53. PubMed ID: 3080538 [Abstract] [Full Text] [Related]
6. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation. Viisoreanu D, Gear A. Thromb Res; 2007 Feb 30; 120(6):885-92. PubMed ID: 17306868 [Abstract] [Full Text] [Related]
7. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets. Martinson EA, Scheible S, Marx-Grunwitz A, Presek P. Thromb Haemost; 1998 Dec 30; 80(6):976-81. PubMed ID: 9869170 [Abstract] [Full Text] [Related]
8. Effects of ethanol on pathways of platelet aggregation in vitro. Rand ML, Packham MA, Kinlough-Rathbone RL, Fraser Mustard J. Thromb Haemost; 1988 Jun 16; 59(3):383-7. PubMed ID: 3142075 [Abstract] [Full Text] [Related]
9. In vitro and in vivo functions of thrombin-treated platelets. Reimers HJ, Kinlough-Rathbone RL, Cazenave JP, Senyi AF, Hirsh J, Packham MA, Mustard JF. Thromb Haemost; 1976 Feb 29; 35(1):151-66. PubMed ID: 785686 [Abstract] [Full Text] [Related]
10. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA. Krishnamurthi S, Joseph S, Kakkar VV. Biochim Biophys Acta; 1987 Mar 11; 927(3):429-36. PubMed ID: 3101746 [Abstract] [Full Text] [Related]
11. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation. Kinlough-Rathbone RL, Packham MA, Guccione MA, Richardson M, Harfenist EJ, Mustard JF. Thromb Haemost; 1991 Apr 08; 65(4):403-10. PubMed ID: 2057923 [Abstract] [Full Text] [Related]
12. Rapid stimulation of tyrosine phosphorylation signals downstream of G-protein-coupled receptors for thromboxane A2 in human platelets. Minuz P, Fumagalli L, Gaino S, Tommasoli RM, Degan M, Cavallini C, Lecchi A, Cattaneo M, Lechi Santonastaso C, Berton G. Biochem J; 2006 Nov 15; 400(1):127-34. PubMed ID: 16859489 [Abstract] [Full Text] [Related]
13. Potentiation by adrenaline of Ca2+ influx and mobilization in stimulated human platelets: dissociation from thromboxane generation and aggregation. Powling MJ, Hardisty RM. Thromb Haemost; 1988 Apr 08; 59(2):212-5. PubMed ID: 3388294 [Abstract] [Full Text] [Related]
14. Pathways responsible for platelet hypersensitivity in rats with diabetes. II. Spontaneous diabetes in BB Wistar rats. Winocour PD, Kinlough-Rathbone RL, Mustard JF. J Lab Clin Med; 1986 Feb 08; 107(2):154-8. PubMed ID: 3080539 [Abstract] [Full Text] [Related]
16. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets. Ciborowski M, Tomasiak M, Rusak T, Winnicka K, Dobrzycki S. Blood Coagul Fibrinolysis; 2008 Sep 08; 19(6):557-67. PubMed ID: 18685439 [Abstract] [Full Text] [Related]
17. Inhibition of platelet aggregation by ethanol in vitro shows specificity for aggregating agent used and is influenced by platelet lipid composition. Fenn CG, Littleton JM. Thromb Haemost; 1982 Aug 24; 48(1):49-53. PubMed ID: 6813995 [Abstract] [Full Text] [Related]
18. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets. Koda M, Banno Y, Naganawa T. Platelets; 2005 Dec 24; 16(8):482-91. PubMed ID: 16287615 [Abstract] [Full Text] [Related]
19. Unexpected effects of aurin tricarboxylic acid on human platelets. Kinlough-Rathbone RL, Packham MA. Thromb Haemost; 1992 Aug 03; 68(2):189-93. PubMed ID: 1412166 [Abstract] [Full Text] [Related]
20. Whole blood platelet aggregation in humans and animals: a comparative study. Soloviev MV, Okazaki Y, Harasaki H. J Surg Res; 1999 Apr 03; 82(2):180-7. PubMed ID: 10090827 [Abstract] [Full Text] [Related] Page: [Next] [New Search]